nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC18A2—type 1 diabetes mellitus	0.482	1	CbGaD
Methamphetamine—Nateglinide—Ramipril—type 1 diabetes mellitus	0.223	0.513	CrCrCtD
Methamphetamine—Aspartame—Ramipril—type 1 diabetes mellitus	0.212	0.487	CrCrCtD
Methamphetamine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00122	0.133	CbGeAlD
Methamphetamine—SLC6A3—nerve—type 1 diabetes mellitus	0.00085	0.093	CbGeAlD
Methamphetamine—MAOB—nerve—type 1 diabetes mellitus	0.000741	0.081	CbGeAlD
Methamphetamine—Lisdexamfetamine—SLC18A2—type 1 diabetes mellitus	0.000713	0.173	CrCbGaD
Methamphetamine—SLC6A2—nerve—type 1 diabetes mellitus	0.000686	0.075	CbGeAlD
Methamphetamine—MAOA—nerve—type 1 diabetes mellitus	0.000632	0.0691	CbGeAlD
Methamphetamine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.000622	0.068	CbGeAlD
Methamphetamine—Ephedrine—SLC18A2—type 1 diabetes mellitus	0.000558	0.135	CrCbGaD
Methamphetamine—Pseudoephedrine—IL2—type 1 diabetes mellitus	0.000483	0.117	CrCbGaD
Methamphetamine—Dextroamphetamine—SLC18A2—type 1 diabetes mellitus	0.000426	0.103	CrCbGaD
Methamphetamine—Nateglinide—ABCC8—type 1 diabetes mellitus	0.00041	0.0992	CrCbGaD
Methamphetamine—Amphetamine—SLC18A2—type 1 diabetes mellitus	0.000343	0.083	CrCbGaD
Methamphetamine—Benzphetamine—SLC18A2—type 1 diabetes mellitus	0.000315	0.0763	CrCbGaD
Methamphetamine—MAOA—islet of Langerhans—type 1 diabetes mellitus	0.000306	0.0335	CbGeAlD
Methamphetamine—MAOB—nephron tubule—type 1 diabetes mellitus	0.000289	0.0316	CbGeAlD
Methamphetamine—Nateglinide—KCNJ11—type 1 diabetes mellitus	0.000289	0.0699	CrCbGaD
Methamphetamine—SLC22A3—kidney—type 1 diabetes mellitus	0.000274	0.03	CbGeAlD
Methamphetamine—MAOA—retina—type 1 diabetes mellitus	0.000262	0.0286	CbGeAlD
Methamphetamine—MAOB—cardiovascular system—type 1 diabetes mellitus	0.000259	0.0284	CbGeAlD
Methamphetamine—MAOB—kidney—type 1 diabetes mellitus	0.000254	0.0278	CbGeAlD
Methamphetamine—MAOA—nephron tubule—type 1 diabetes mellitus	0.000246	0.027	CbGeAlD
Methamphetamine—SLC22A5—retina—type 1 diabetes mellitus	0.000241	0.0264	CbGeAlD
Methamphetamine—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000237	0.0259	CbGeAlD
Methamphetamine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000235	0.0257	CbGeAlD
Methamphetamine—SLC22A5—nephron tubule—type 1 diabetes mellitus	0.000227	0.0248	CbGeAlD
Methamphetamine—MAOA—cardiovascular system—type 1 diabetes mellitus	0.000221	0.0242	CbGeAlD
Methamphetamine—MAOA—kidney—type 1 diabetes mellitus	0.000217	0.0237	CbGeAlD
Methamphetamine—MAOA—pancreas—type 1 diabetes mellitus	0.000215	0.0235	CbGeAlD
Methamphetamine—ADRA2C—kidney—type 1 diabetes mellitus	0.000208	0.0228	CbGeAlD
Methamphetamine—ADRA2C—pancreas—type 1 diabetes mellitus	0.000207	0.0226	CbGeAlD
Methamphetamine—Phenylpropanolamine—ADRB1—type 1 diabetes mellitus	0.000203	0.0492	CrCbGaD
Methamphetamine—SLC22A5—kidney—type 1 diabetes mellitus	0.000199	0.0218	CbGeAlD
Methamphetamine—Pseudoephedrine—ADRB1—type 1 diabetes mellitus	0.000172	0.0416	CrCbGaD
Methamphetamine—ADRA2A—pancreas—type 1 diabetes mellitus	0.000165	0.0181	CbGeAlD
Methamphetamine—Pseudoephedrine—TNF—type 1 diabetes mellitus	0.000163	0.0394	CrCbGaD
Methamphetamine—CYP2D6—kidney—type 1 diabetes mellitus	0.000129	0.0141	CbGeAlD
Methamphetamine—Nateglinide—ALB—type 1 diabetes mellitus	6.02e-05	0.0146	CrCbGaD
Methamphetamine—SLC6A4—Circadian rythm related genes—IL6—type 1 diabetes mellitus	1.92e-05	0.000274	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—VAV1—type 1 diabetes mellitus	1.91e-05	0.000273	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—SST—type 1 diabetes mellitus	1.91e-05	0.000273	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	1.91e-05	0.000272	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	1.9e-05	0.000271	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	1.9e-05	0.000271	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—INS—type 1 diabetes mellitus	1.87e-05	0.000266	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IAPP—type 1 diabetes mellitus	1.85e-05	0.000264	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.84e-05	0.000263	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.84e-05	0.000262	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.81e-05	0.000258	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.8e-05	0.000256	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IL2RA—type 1 diabetes mellitus	1.8e-05	0.000256	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	1.79e-05	0.000255	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—SST—type 1 diabetes mellitus	1.79e-05	0.000255	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	1.78e-05	0.000254	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	1.77e-05	0.000252	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—SST—type 1 diabetes mellitus	1.74e-05	0.000248	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IGF2—type 1 diabetes mellitus	1.73e-05	0.000247	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	1.73e-05	0.000247	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—GCG—type 1 diabetes mellitus	1.71e-05	0.000243	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ABCC8—type 1 diabetes mellitus	1.7e-05	0.000242	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ITPR3—type 1 diabetes mellitus	1.7e-05	0.000242	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CAT—type 1 diabetes mellitus	1.68e-05	0.000239	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—GCG—type 1 diabetes mellitus	1.68e-05	0.000239	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.67e-05	0.000238	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	1.66e-05	0.000237	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	1.66e-05	0.000236	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—KCNJ11—type 1 diabetes mellitus	1.65e-05	0.000236	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—NOS2—type 1 diabetes mellitus	1.65e-05	0.000236	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	1.65e-05	0.000236	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	1.64e-05	0.000234	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.64e-05	0.000234	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—SST—type 1 diabetes mellitus	1.62e-05	0.000231	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	1.62e-05	0.00023	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	1.61e-05	0.000229	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—HBA1—type 1 diabetes mellitus	1.6e-05	0.000228	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	1.59e-05	0.000227	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—GCG—type 1 diabetes mellitus	1.59e-05	0.000227	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	1.59e-05	0.000227	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—APOC3—type 1 diabetes mellitus	1.59e-05	0.000226	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GSTT1—type 1 diabetes mellitus	1.56e-05	0.000222	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.55e-05	0.000221	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NOS2—type 1 diabetes mellitus	1.55e-05	0.00022	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	1.53e-05	0.000219	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	1.5e-05	0.000214	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GAL—type 1 diabetes mellitus	1.5e-05	0.000214	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.49e-05	0.000213	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	1.49e-05	0.000212	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	1.49e-05	0.000212	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.48e-05	0.000211	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.48e-05	0.000211	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IGF1—type 1 diabetes mellitus	1.47e-05	0.000209	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IL2RA—type 1 diabetes mellitus	1.46e-05	0.000208	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—SST—type 1 diabetes mellitus	1.45e-05	0.000207	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.45e-05	0.000206	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.45e-05	0.000206	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	1.45e-05	0.000206	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.44e-05	0.000206	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.43e-05	0.000204	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CAT—type 1 diabetes mellitus	1.42e-05	0.000202	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GAL—type 1 diabetes mellitus	1.4e-05	0.000199	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ITPR3—type 1 diabetes mellitus	1.4e-05	0.000199	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.39e-05	0.000199	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	1.39e-05	0.000199	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.39e-05	0.000198	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—ALB—type 1 diabetes mellitus	1.39e-05	0.000198	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.39e-05	0.000198	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.38e-05	0.000197	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.38e-05	0.000197	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.38e-05	0.000197	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IGF1—type 1 diabetes mellitus	1.37e-05	0.000195	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	1.36e-05	0.000194	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.35e-05	0.000193	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.35e-05	0.000192	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—KCNJ11—type 1 diabetes mellitus	1.34e-05	0.000192	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—NOS3—type 1 diabetes mellitus	1.33e-05	0.00019	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—SST—type 1 diabetes mellitus	1.32e-05	0.000188	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—HBA1—type 1 diabetes mellitus	1.31e-05	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	1.31e-05	0.000187	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—APOC3—type 1 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CHRM2—type 1 diabetes mellitus	1.3e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—ALB—type 1 diabetes mellitus	1.3e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	1.29e-05	0.000185	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTT1—type 1 diabetes mellitus	1.28e-05	0.000183	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	1.28e-05	0.000182	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.27e-05	0.000181	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NOS2—type 1 diabetes mellitus	1.26e-05	0.000179	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.25e-05	0.000178	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	1.25e-05	0.000178	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GCG—type 1 diabetes mellitus	1.24e-05	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—NOS3—type 1 diabetes mellitus	1.24e-05	0.000177	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.23e-05	0.000176	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.22e-05	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	1.21e-05	0.000173	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	1.21e-05	0.000172	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.18e-05	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—GCG—type 1 diabetes mellitus	1.18e-05	0.000168	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.17e-05	0.000167	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.17e-05	0.000167	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.17e-05	0.000167	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.17e-05	0.000166	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	1.15e-05	0.000164	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GAL—type 1 diabetes mellitus	1.14e-05	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	1.14e-05	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ITPR3—type 1 diabetes mellitus	1.13e-05	0.000162	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	1.13e-05	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IL2—type 1 diabetes mellitus	1.13e-05	0.000161	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL11—type 1 diabetes mellitus	1.12e-05	0.00016	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	1.12e-05	0.00016	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.12e-05	0.00016	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IGF1—type 1 diabetes mellitus	1.11e-05	0.000159	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—INS—type 1 diabetes mellitus	1.11e-05	0.000159	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	1.11e-05	0.000158	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.1e-05	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.1e-05	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	1.1e-05	0.000157	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	1.1e-05	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.09e-05	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.09e-05	0.000156	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—HBA1—type 1 diabetes mellitus	1.07e-05	0.000152	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.06e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APOC3—type 1 diabetes mellitus	1.06e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	1.06e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—ALB—type 1 diabetes mellitus	1.05e-05	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IL2—type 1 diabetes mellitus	1.05e-05	0.00015	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CAT—type 1 diabetes mellitus	1.05e-05	0.00015	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.05e-05	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTT1—type 1 diabetes mellitus	1.04e-05	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.03e-05	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SST—type 1 diabetes mellitus	1.03e-05	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GCG—type 1 diabetes mellitus	1.02e-05	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.02e-05	0.000146	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ALB—type 1 diabetes mellitus	1.02e-05	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—NOS3—type 1 diabetes mellitus	1.01e-05	0.000144	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—NOS3—type 1 diabetes mellitus	9.76e-06	0.000139	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SST—type 1 diabetes mellitus	9.59e-06	0.000137	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.55e-06	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	9.49e-06	0.000135	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—INS—type 1 diabetes mellitus	9.42e-06	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	9.36e-06	0.000133	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	9.22e-06	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GCG—type 1 diabetes mellitus	9.15e-06	0.00013	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	8.93e-06	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	8.87e-06	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	8.87e-06	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.81e-06	0.000126	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	8.76e-06	0.000125	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CAT—type 1 diabetes mellitus	8.65e-06	0.000123	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ALB—type 1 diabetes mellitus	8.63e-06	0.000123	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.55e-06	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IL2—type 1 diabetes mellitus	8.55e-06	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GCG—type 1 diabetes mellitus	8.55e-06	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.53e-06	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	8.5e-06	0.000121	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	8.37e-06	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	8.3e-06	0.000118	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—NOS3—type 1 diabetes mellitus	8.26e-06	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.23e-06	0.000117	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—type 1 diabetes mellitus	8.17e-06	0.000116	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.99e-06	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.97e-06	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	7.79e-06	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.78e-06	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	7.76e-06	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.75e-06	0.00011	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CD86—type 1 diabetes mellitus	7.46e-06	0.000106	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	7.39e-06	0.000105	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.26e-06	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.24e-06	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.13e-06	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.08e-06	0.000101	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	7.03e-06	0.0001	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—INS—type 1 diabetes mellitus	6.98e-06	9.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CD86—type 1 diabetes mellitus	6.97e-06	9.93e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	6.96e-06	9.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	6.94e-06	9.9e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	6.91e-06	9.86e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	6.79e-06	9.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.73e-06	9.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	6.68e-06	9.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.66e-06	9.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.62e-06	9.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.61e-06	9.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.52e-06	9.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.49e-06	9.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.47e-06	9.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.47e-06	9.23e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—type 1 diabetes mellitus	6.4e-06	9.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.28e-06	8.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.18e-06	8.81e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NOS3—type 1 diabetes mellitus	6.12e-06	8.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.09e-06	8.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.04e-06	8.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	5.9e-06	8.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.88e-06	8.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	5.74e-06	8.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	5.66e-06	8.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	5.44e-06	7.76e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.41e-06	7.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.41e-06	7.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.37e-06	7.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	5.27e-06	7.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	5.14e-06	7.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.1e-06	7.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	5.08e-06	7.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	5.04e-06	7.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.02e-06	7.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.97e-06	7.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.95e-06	7.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.95e-06	7.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.91e-06	7e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	4.8e-06	6.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	4.67e-06	6.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.65e-06	6.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.62e-06	6.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.59e-06	6.55e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.58e-06	6.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.51e-06	6.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.29e-06	6.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	4.28e-06	6.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.21e-06	6.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.13e-06	5.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	4.09e-06	5.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	3.9e-06	5.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.83e-06	5.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	3.82e-06	5.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.8e-06	5.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.77e-06	5.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.75e-06	5.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.58e-06	5.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	3.57e-06	5.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.55e-06	5.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.49e-06	4.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.42e-06	4.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.22e-06	4.59e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.04e-06	4.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3e-06	4.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.92e-06	4.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.9e-06	4.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.9e-06	4.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.89e-06	4.11e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.79e-06	3.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.73e-06	3.89e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.67e-06	3.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.44e-06	3.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.25e-06	3.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.22e-06	3.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.1e-06	2.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.7e-06	2.43e-05	CbGpPWpGaD
